A non-interventional, retrospective/prospective, multicenter, single arm study evaluating the effectiveness and safety of Polatuzumab vedotin plus R-CHP in realworld clinical practice among italian adult patients with untreated Diffuse Large B-cell…

A non-interventional, retrospective/prospective, multicenter, single arm study evaluating the effectiveness and safety of Polatuzumab vedotin plus R-CHP in realworld clinical practice among italian adult patients with untreated Diffuse Large B-cell Lymphoma

Promotore
Roche S.p.A
Acronimo
ML45152 (POLARWOLF)
Struttura
Ematologia
Sperimentatore principale
Zanni Manuela
Stato arruolamento
In attesa di arruolamento
Linee di ricerca
Linfoma non Hodgkin